PLUS1
51.86
-0.93 (-1.76%)
-0.93 (-1.76%)
Upgrade to Real-Time
Regular Market
| Volume | 407,279 |
|
|||||
| News | (1) | ||||||
| Day High | 52.52 | Low High |
|||||
| Day Low | 49.34 | ||||||
Best deals to access real time data! |
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
USA Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | ARWR | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| -0.93 | -1.76% | 51.86 | 07:16:03 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 51.45 | 49.34 | 52.52 | 52.79 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,007 | 407,279 | US$ 50.69 | US$ 20,643,969 | - | 47.2919 - 93.66 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:15:58 | 21 | US$ 51.9132 | USD |
Period:
Draw Mode:
Arrowhead Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 5.42B | 104.53M | 89.33M | US$ 138.29M | US$ -107.13M | -1.36 | -37.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -87.90k | 6.40% |
Arrowhead Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 26/1/2022 | 07:07 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 13/1/2022 | 00:09 | Seeking Alpha | Arrowhead Pharma initiates late-stage ARO-APOC3 study for.. |
| 23/12/2021 | 08:46 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
| 21/12/2021 | 00:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 16/12/2021 | 22:09 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/12/2021 | 00:41 | PR Newswire (US) | Direxion Launches mRNA ETF (MSGR) |
| 23/11/2021 | 08:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 23/11/2021 | 08:55 | Dow Jones News | Arrowhead Pharma in License Agreement With GSK for ARO-HSD |
| 23/11/2021 | 08:34 | Edgar (US Regulatory) | Annual Report (10-k) |
| 23/11/2021 | 08:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 23/11/2021 | 08:03 | Seeking Alpha | Arrowhead Pharmaceuticals EPS misses by $0.77, misses on.. |
| 20/11/2021 | 09:35 | Seeking Alpha | Arrowhead Pharmaceuticals FY 2021 Earnings Preview |
Historical ARWR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 56.39 | 56.4699 | 47.2919 | 52.70 | 791,051 | -4.53 | -8.03% |
| 1 Month | 66.50 | 70.09 | 47.2919 | 59.13 | 640,362 | -14.64 | -22.02% |
| 3 Months | 70.79 | 84.83 | 47.2919 | 67.48 | 699,435 | -18.93 | -26.74% |
| 6 Months | 68.20 | 84.83 | 47.2919 | 65.86 | 605,272 | -16.34 | -23.96% |
| 1 Year | 81.85 | 93.66 | 47.2919 | 70.57 | 723,703 | -29.99 | -36.64% |
| 3 Years | 13.10 | 93.66 | 12.72 | 45.12 | 1,277,210 | 38.76 | 295.88% |
| 5 Years | 1.75 | 93.66 | 1.42 | 29.63 | 1,356,572 | 50.11 | 2,863.43% |
